XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Oct. 31, 2024
Jan. 31, 2024
Current assets:    
Cash and cash equivalents $ 1,273,823 $ 1,558,252
Marketable securities 6,428,214 5,404,233
Accounts receivable, net of allowances of $23,724 and $32,371 as of October 31, 2024 and January 31, 2024, respectively 458,007 536,078
Deferred contract acquisition costs, current 189,874 208,474
Prepaid expenses and other current assets 182,497 219,182
Total current assets 8,532,415 7,926,219
Deferred contract acquisition costs, noncurrent 113,079 138,724
Property and equipment, net 340,750 293,704
Operating lease right-of-use assets 56,878 58,975
Strategic investments 444,653 409,222
Goodwill 307,295 307,295
Deferred tax assets 730,601 662,177
Other assets, noncurrent 154,198 133,477
Total assets 10,679,869 9,929,793
Current liabilities:    
Accounts payable 8,542 10,175
Accrued expenses and other current liabilities 481,492 500,164
Deferred revenue, current 1,363,392 1,251,848
Total current liabilities 1,853,426 1,762,187
Deferred revenue, noncurrent 15,559 18,514
Operating lease liabilities, noncurrent 37,590 48,308
Other liabilities, noncurrent 93,460 81,378
Total liabilities 2,000,035 1,910,387
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Common stock, $0.001 par value per share, 2,000,000,000 Class A shares authorized as of October 31, 2024 and January 31, 2024; 260,989,188 and 260,896,822 shares issued and outstanding as of October 31, 2024 and January 31, 2024, respectively; 300,000,000 Class B shares authorized as of October 31, 2024 and January 31, 2024; 45,635,091 and 46,661,531 shares issued and outstanding as of October 31, 2024 and January 31, 2024, respectively 306 307
Additional paid-in capital 5,241,088 5,228,756
Accumulated other comprehensive income 6,787 1,063
Retained earnings 3,431,653 2,789,280
Total stockholders’ equity 8,679,834 8,019,406
Total liabilities and stockholders’ equity $ 10,679,869 $ 9,929,793